Cargando…

Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys

BACKGROUND: Pathology and laboratory medicine diagnostics and diagnostic imaging are crucial to achieving universal health coverage. We analysed Service Provision Assessments (SPAs) from ten low-income and middle-income countries to benchmark diagnostic availability. METHODS: Diagnostic availabiliti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Harika, Shah, Devanshi, Sayed, Shahin, Horton, Susan, Schroeder, Lee F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526361/
https://www.ncbi.nlm.nih.gov/pubmed/34626546
http://dx.doi.org/10.1016/S2214-109X(21)00442-3
_version_ 1784585859040804864
author Yadav, Harika
Shah, Devanshi
Sayed, Shahin
Horton, Susan
Schroeder, Lee F
author_facet Yadav, Harika
Shah, Devanshi
Sayed, Shahin
Horton, Susan
Schroeder, Lee F
author_sort Yadav, Harika
collection PubMed
description BACKGROUND: Pathology and laboratory medicine diagnostics and diagnostic imaging are crucial to achieving universal health coverage. We analysed Service Provision Assessments (SPAs) from ten low-income and middle-income countries to benchmark diagnostic availability. METHODS: Diagnostic availabilities were determined for Bangladesh, Haiti, Malawi, Namibia, Nepal, Kenya, Rwanda, Senegal, Tanzania, and Uganda, with multiple timepoints for Haiti, Kenya, Senegal, and Tanzania. A smaller set of diagnostics were included in the analysis for primary care facilities compared with those expected at hospitals, with 16 evaluated in total. Surveys spanned 2004–18, including 8512 surveyed facilities. Country-specific facility types were mapped to basic primary care, advanced primary care, or hospital tiers. We calculated percentages of facilities offering each diagnostic, accounting for facility weights, stratifying by tier, and for some analyses, region. The tier-level estimate of diagnostic availability was defined as the median of all diagnostic-specific availabilities at each tier, and country-level estimates were the median of all diagnostic-specific availabilities of each of the tiers. Associations of country-level diagnostic availability with country income as well as (within-country) region-level availability with region-specific population densities were determined by multivariable linear regression, controlling for appropriate covariates including tier. FINDINGS: Median availability of diagnostics was 19·1% in basic primary care facilities, 49·2% in advanced primary care facilities, and 68·4% in hospitals. Availability varied considerably between diagnostics, ranging from 1·2% (ultrasound) to 76·7% (malaria) in primary care (basic and advanced) and from 6·1% (CT scan) to 91·6% (malaria) in hospitals. Availability also varied between countries, from 14·9% (Bangladesh) to 89·6% (Namibia). Availability correlated positively with log(income) at both primary care tiers but not the hospital tier, and positively with region-specific population density at the basic primary care tier only. INTERPRETATION: Major gaps in diagnostic availability exist in many low-income and middle-income countries, particularly in primary care facilities. These results can serve as a benchmark to gauge progress towards implementing guidelines such as the WHO Essential Diagnostics List and Priority Medical Devices initiatives. FUNDING: Bill & Melinda Gates Foundation.
format Online
Article
Text
id pubmed-8526361
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd
record_format MEDLINE/PubMed
spelling pubmed-85263612021-10-25 Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys Yadav, Harika Shah, Devanshi Sayed, Shahin Horton, Susan Schroeder, Lee F Lancet Glob Health Articles BACKGROUND: Pathology and laboratory medicine diagnostics and diagnostic imaging are crucial to achieving universal health coverage. We analysed Service Provision Assessments (SPAs) from ten low-income and middle-income countries to benchmark diagnostic availability. METHODS: Diagnostic availabilities were determined for Bangladesh, Haiti, Malawi, Namibia, Nepal, Kenya, Rwanda, Senegal, Tanzania, and Uganda, with multiple timepoints for Haiti, Kenya, Senegal, and Tanzania. A smaller set of diagnostics were included in the analysis for primary care facilities compared with those expected at hospitals, with 16 evaluated in total. Surveys spanned 2004–18, including 8512 surveyed facilities. Country-specific facility types were mapped to basic primary care, advanced primary care, or hospital tiers. We calculated percentages of facilities offering each diagnostic, accounting for facility weights, stratifying by tier, and for some analyses, region. The tier-level estimate of diagnostic availability was defined as the median of all diagnostic-specific availabilities at each tier, and country-level estimates were the median of all diagnostic-specific availabilities of each of the tiers. Associations of country-level diagnostic availability with country income as well as (within-country) region-level availability with region-specific population densities were determined by multivariable linear regression, controlling for appropriate covariates including tier. FINDINGS: Median availability of diagnostics was 19·1% in basic primary care facilities, 49·2% in advanced primary care facilities, and 68·4% in hospitals. Availability varied considerably between diagnostics, ranging from 1·2% (ultrasound) to 76·7% (malaria) in primary care (basic and advanced) and from 6·1% (CT scan) to 91·6% (malaria) in hospitals. Availability also varied between countries, from 14·9% (Bangladesh) to 89·6% (Namibia). Availability correlated positively with log(income) at both primary care tiers but not the hospital tier, and positively with region-specific population density at the basic primary care tier only. INTERPRETATION: Major gaps in diagnostic availability exist in many low-income and middle-income countries, particularly in primary care facilities. These results can serve as a benchmark to gauge progress towards implementing guidelines such as the WHO Essential Diagnostics List and Priority Medical Devices initiatives. FUNDING: Bill & Melinda Gates Foundation. Elsevier Ltd 2021-10-06 /pmc/articles/PMC8526361/ /pubmed/34626546 http://dx.doi.org/10.1016/S2214-109X(21)00442-3 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Yadav, Harika
Shah, Devanshi
Sayed, Shahin
Horton, Susan
Schroeder, Lee F
Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys
title Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys
title_full Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys
title_fullStr Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys
title_full_unstemmed Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys
title_short Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys
title_sort availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526361/
https://www.ncbi.nlm.nih.gov/pubmed/34626546
http://dx.doi.org/10.1016/S2214-109X(21)00442-3
work_keys_str_mv AT yadavharika availabilityofessentialdiagnosticsintenlowincomeandmiddleincomecountriesresultsfromnationalhealthfacilitysurveys
AT shahdevanshi availabilityofessentialdiagnosticsintenlowincomeandmiddleincomecountriesresultsfromnationalhealthfacilitysurveys
AT sayedshahin availabilityofessentialdiagnosticsintenlowincomeandmiddleincomecountriesresultsfromnationalhealthfacilitysurveys
AT hortonsusan availabilityofessentialdiagnosticsintenlowincomeandmiddleincomecountriesresultsfromnationalhealthfacilitysurveys
AT schroederleef availabilityofessentialdiagnosticsintenlowincomeandmiddleincomecountriesresultsfromnationalhealthfacilitysurveys